Boston Scientific
552 hedge funds and large institutions have $31.5B invested in Boston Scientific in 2017 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 180 increasing their positions, 227 reducing their positions, and 61 closing their positions.
22% more funds holding in top 10
Funds holding in top 10: 9 → 11 (+2)
16% more capital invested
Capital invested by funds: $27.2B → $31.5B (+$4.33B)
13% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 61
0.29% more ownership
Funds ownership: 92.31% → 92.6% (+0.29%)
0% more call options, than puts
Call options by funds: $39.8M | Put options by funds: $39.8M
1% less funds holding
Funds holding: 556 → 552 (-4)
21% less repeat investments, than reductions
Existing positions increased: 180 | Existing positions reduced: 227
Top Buyers
| 1 |
BlackRock
New York
|
+$2.23B |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$342M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$319M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$116M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$85.2M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$164M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$134M |
| 3 |
Bank of New York Mellon
New York
|
-$112M |
| 4 |
State Street
Boston,
Massachusetts
|
-$94.2M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$92.6M |
BSX Hedge Fund Activity: Q1 2017 in Review
552 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2017, worth a combined $31.5B — up 16% from $27.2B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new BSX positions and 61 closed out — a net gain of 8 holders — while 180 added to existing stakes and 227 trimmed.
The largest buyer was BlackRock, adding an estimated $2.23B. The largest seller was Citadel Advisors, cutting an estimated $164M.
- 552 institutional investors held Boston Scientific (BSX) as of Q1 2017, down from 556 in Q4 2016.
- Funds reported $31.5B of Boston Scientific stock for Q1 2017, up 16% quarter-over-quarter.
- 69 funds opened new Boston Scientific positions in Q1 2017 and 61 closed out, a net change of +8 holders.
- The largest Boston Scientific buyer in Q1 2017 was BlackRock, an estimated $2.23B added.
- The largest Boston Scientific seller in Q1 2017 was Citadel Advisors, an estimated $164M sold.
Based on aggregated 13F filings for Q1 2017.